Jamie Landman

University of California, Irvine Medical Center

Papers

1

Total Citations

48

H-Index

1

About

Dr. Jamie Landman is a pioneering urologic surgeon whose research has fundamentally shaped the management of small renal masses (SRMs) and nephron-sparing surgery. His key contributions lie in optimizing surgical techniques for kidney cancer, with a particular focus on comparing oncologic and functional outcomes across different treatment modalities. In his highly cited 2015 study, "Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements" (48 citations), Dr. Landman provided critical insights into how different nephron-sparing procedures—including partial nephrectomy, cryoablation, and radiofrequency ablation—affect renal parenchymal volume preservation. This work has been instrumental in guiding clinical decision-making for patients with SRMs, helping surgeons balance cancer control with maximal kidney function retention. Dr. Landman’s research is widely recognized for its methodological rigor and clinical relevance, earning him a reputation as a leading authority in urologic oncology. His contributions continue to influence surgical practice and improve outcomes for patients with kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements
48 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of California, Irvine Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago